COVID: Another 179,756 daily coronavirus cases and 231 deaths reported in UK
Another 179,756 COVID cases and 231 deaths have been reported in the UK, latest daily figures show.
Both figures are down on the 194,747 infections and 334 fatalities confirmed yesterday.
The latest count of COVID patients in hospital is 17,988, which is up on the 17,276 last reported. Of those, 875 require ventilation beds, down from 911.
Lamb Weston Holdings, Inc. Q2 Profit Decreases, but beats estimates
Lamb Weston Holdings, Inc. (LW) reported earnings for second quarter that decreased from the same period last year but beat the Street estimates.
The company’s earnings totaled $32.5 million, or $0.22 per share. This compares with $96.9 million, or $0.66 per share, in last year’s second quarter.
Excluding items, Lamb Weston Holdings, Inc. reported adjusted earnings of $73.0 million or $0.50 per share for the period.
Analysts on average had expected the company to earn $0.32 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.
The company’s revenue for the quarter rose 12.2% to $1.01 billion from $0.90 billion last year.
Lamb Weston Holdings, Inc. earnings at a glance:
-Earnings (Q2): $32.5 Mln. vs. $96.9 Mln. last year.
-EPS (Q2): $0.22 vs. $0.66 last year.
-Analyst Estimates: $0.32
-Revenue (Q2): $1.01 Bln vs. $0.90 Bln last year.
Electric car sales boom, the ‘great resignation’ phenomenon and could pet food go vegan?
The latest as new figures show a boom in the sale of electric cars over the past year.
Ian also speaks to Atif Sheikh, the chief executive and founder of consultancy businessfourzero, about the millions who walked away from their jobs in 2021 as they reappraised their lives in the pandemic.
And as many go meat-free for Veganuary – one pet food maker is hoping dogs can change their diet all-year round.
Treasury Announces Details Of 3-Year, 10-Year Note & 30-Year Bond Auctions
The Treasury Department on Thursday announced the details of this month’s auctions of three-year and ten-year notes and thirty-year bonds.
The Treasury revealed it plans to sell $52 billion worth of three-year notes, $36 billion worth of ten-year notes and $22 billion worth of thirty-year bonds.
The results of the three-year note auction will be announced next Tuesday, the results of the ten-year note auction will be announced next Wednesday and the results of the thirty-year bond auction will be announced next Thursday.
Last month, the Treasury sold $54 billion worth of three-year notes, $36 billion worth of ten-year notes and $22 billion worth of thirty-year bonds.
The three-year note auction attracted average demand, while the ten-year note and thirty-year bond auctions attracted modestly below average demand.
Constellation Brands Q3 Profit Tops Estimates; Increases FY22 Comparable Basis EPS outlook
Constellation Brands, Inc. (STZ) reported third quarter comparable earnings per share of $3.12 compared to $3.09, prior year. This included Canopy equity losses of $0.31, for the quarter. Excluding Canopy equity losses, the company reported comparable basis earnings per share of $3.42, an increase of 8%. On average, 16 analysts polled by Thomson Reuters expected the company to report profit per share of $2.76, for the quarter. Analysts’ estimates typically exclude special items.
Net income attributable to CBI declined to $470.8 million or $2.48 per share from $1.28 billion or $6.55 per share, prior year.
Net sales decreased to $2.32 billion from $2.44 billion, last year. Analysts on average had estimated $2.28 billion in revenue.
For the year ending February 28, 2022, the company projects comparable basis, earnings per share, excluding Canopy in a range of $10.50 to $10.65.
Mainz Biomed Shares Down 5%, Reversing Uptrend
Shares of molecular genetics diagnostic company Mainz Biomed B.V. (MYNZ) are down 5 percent on Thursday’s trading, thus breaking the stock’s upward movement since Wednesday after the company announced that it had acquired exclusive rights to novel mRNA biomarkers.
Mainz Biomed had entered into a Technology Rights Agreement with Socpra Sciences Santé Et Humaines S.E.C. to access a portfolio of novel mRNA biomarkers for potential future integration into ColoAlert, the company’s easy-to-use detection test for colorectal cancer.
Currently at $13.85, the stock has traded between $7.80 and $18.68 during the past 52 weeks.
Curis Shares Down 27%
Curis, Inc. (CRIS) shares are declining more than 28 percent on Thursday morning trade after the company updated phase 1 /2 study of CA – 4948 monotherapy in targeted patients with relapsed or refractory acute myeloid leukemia or AML and myelodysplastic syndrome or MDS. The shares have been declining since January 4th.
Currently, shares are at $3.46, up 28.36 percent from the previous close of $4.83 on a volume of 4,130,703. The shares have traded in a range of $3.32-$4.80 on average volume of 1,566,961 for the last 52 weeks.
U.S. Factory Orders Jump More Than Expected In November
A report released by the Commerce Department on Thursday showed new orders for U.S. manufactured goods increased by more than expected in the month of November.
The Commerce Department said factory orders surged up by 1.6 percent in November after jumping by an upwardly revised 1.2 percent in October.
Economists had expected factory orders to shoot up by 1.3 percent compared to the 1.0 percent advance originally reported for the previous month.
The bigger than expected increase in factory orders came as orders for durable goods spiked by 2.6 percent, while orders for non-durable goods rose by 0.7 percent.
The report also showed shipments of manufactured goods increased by 0.7 percent in November after jumping by 2.0 percent in October.
Inventories of manufactured goods also advanced by 0.7 percent in November following a 0.9 percent increase in the previous month.
With inventories and shipments rising at the same rate, the inventories-to-shipments ratio was unchanged from the previous month at 1.46.